The forecasted data indicates a declining trend in trachea, bronchus, and lung malignant neoplasms mortality rates among men in Japan from 2024 to 2028. The standardized rate decreases from 53.4 deaths per hundred thousand men in 2024 to 50.0 in 2028. This suggests a year-on-year decline of approximately 1.7% to 1.8%. The compound annual growth rate (CAGR) over this five-year span is approximately -1.6%, indicating a consistent reduction in mortality rates.
Key future trends to watch for include advancements in early detection techniques and therapies, public health initiatives targeting smoking cessation, and improving air quality, all of which could further influence mortality rates. Monitoring these factors will be crucial in predicting long-term outcomes and improving survival rates.
